Viking Global Opportunities Illiquid Investments Sub-Master LP, 10% Owner at Amylyx Pharmaceuticals, Inc. (AMLX), bought 7,170,536 shares at $19.00 ($43.7M) on 2022-01-11, disclosed to the SEC on 2022-01-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 4,870,536 | $0 | 0.0% |
| 2 | $19.00 | 2,300,000 | $43.7M | 100.0% |
| Total | $6.09 avg | 7,170,536 | $43.7M | 100% |
| Filing → |
| FDMT | SELL | 2024-01-05 | $10.5M | — | Filing → |
| AMLX | SELL | 2022-09-09 | $83.4M | — | Filing → |
| RLYB | BUY | 2021-08-02 | $10.5M | — | Filing → |